Ligand validation:7L6C

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7L6C designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7L6C_NAD_B_301	97%	64%	0.063	0.978	0.59	0.77	-	2	0	0	100%	1
7L6C_NAD_A_301	97%	60%	0.072	0.984	0.74	0.79	-	2	0	0	100%	1
7L6C_NAD_C_301	95%	62%	0.07	0.974	0.6	0.85	-	2	0	0	100%	1
7L6C_NAD_D_301	78%	64%	0.103	0.945	0.59	0.79	-	2	1	0	100%	1
7U0M_NAD_B_301	96%	65%	0.068	0.978	0.57	0.78	-	2	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
2BJK_NAD_A_1517	100%	59%	0.025	0.995	0.72	0.86	-	1	1	0	100%	0.86
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.